Preview

Russian Journal of Cardiology

Advanced search
Fullscreen

For citations:


Lozhkina N.G., Dobrovolskaya N.P., Artemenko S.N., Shipunov M.V., Sharonin A.D., Koltyugina V.A., Timofeev V.S., Voyevoda M.I. Efficacy and safety of inclisiran, evolocumab and alirocumab in patients with high, very high and extreme cardiovascular risk. Russian Journal of Cardiology. 2025;30(3):5869. (In Russ.) https://doi.org/10.15829/1560-4071-2025-5869. EDN: RZWJCG

Views PDF (Rus): 84


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)